GlaxoSmithKline PLC (NYSE:GSK)

41.32
Delayed Data
As of Jul 23
 +0.19 / +0.46%
Today’s Change
36.41
Today|||52-Week Range
42.20
+8.14%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$102.2B

Company Description

GlaxoSmithKline Plc is a global healthcare company which engages in researching, developing and manufacturing of pharmaceutical medicines, vaccines and consumer healthcare products. It operates through the following four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare. The Pharmaceuticals segment researches, develops and makes available medicines that treat a variety of serious and chronic diseases. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis. The Consumer Healthcare segment markets a range of consumer health products based on scientific innovation. The company was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Contact Information

GlaxoSmithKline Plc
980 Great West Road
Brentford Greater London TW8 9GS
P:442080475000
Investor Relations:

Employees

Shareholders

Other institutional7.75%
Mutual fund holders3.77%
Individual stakeholders--

Top Executives

Emma WalmsleyChief Executive Officer & Executive Director
Iain James MackayChief Financial Officer & Executive Director
Jon EllisVice President & Head-Science & Technology
Karenann K. TerrellChief Technology & Digital Officer
Hal V. BarronExecutive Director & Chief Scientific Officer